Terms: = Endocrine gland cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M
44 results:
1. Imprint Cytology of Tall Cell Carcinoma with Reversed Polarity of the Breast: A Case Report.
Shinomiya Y; Kouchi Y; Onodera K; Yamamoto H; Harada-Kagitani S; Sakakibara J; Nagashima T; Ikeda JI; Kishimoto T
Acta Cytol; 2024; 68(1):73-79. PubMed ID: 38262369
[TBL] [Abstract] [Full Text] [Related]
2. Mutation analysis of the TERT gene in ovarian cancer patients of the Turkish population by next generation sequencing method.
Capar Gorali B; Gulec Yılmaz S; Akdeniz FT; Attar R; İsbir T
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):51-55. PubMed ID: 38015541
[TBL] [Abstract] [Full Text] [Related]
3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
4. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.
Wang Y; Liu B; Li F; Zhang Y; Gao X; Wang Y; Zhou H
Front Endocrinol (Lausanne); 2023; 14():1274239. PubMed ID: 37867526
[TBL] [Abstract] [Full Text] [Related]
5. Hypoxia-associated genetic signature in ovarian steroid cell tumor NOS.
Chao A; Huang HJ; Lin CY; Lee CH; Lin CH; Chao AS; Lai CH; Chang TC; Wu KY; Wu RC
Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37655726
[TBL] [Abstract] [Full Text] [Related]
6. EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.
Chen J; Hong JH; Huang Y; Liu S; Yin J; Deng P; Sun Y; Yu Z; Zeng X; Xiao R; Chan JY; Guan P; Wang Y; Wang P; Liu L; Wen S; Yu Q; Ong CK; Teh BT; Xiong Y; Tan J
Mol Cancer; 2023 May; 22(1):85. PubMed ID: 37210576
[TBL] [Abstract] [Full Text] [Related]
7. Identification of potential diagnostic and prognostic biomarkers for papillary thyroid microcarcinoma (PTMC) based on TMT-labeled LC-MS/MS and machine learning.
Li J; Mi L; Ran B; Sui C; Zhou L; Li F; Dionigi G; Sun H; Liang N
J Endocrinol Invest; 2023 Jun; 46(6):1131-1143. PubMed ID: 36418670
[TBL] [Abstract] [Full Text] [Related]
8. Adrenal Cortical Carcinoma and Additional Rare Pathologic Findings in Multi-Organs in a Birt-Hogg-Dubé Syndrome Patient: With an Emphasis on the Molecular Characteristics of Adrenal Cortical Carcinoma.
Kim D; Murvelashvili N; Hamidi O; Jia L
Int J Surg Pathol; 2023 Aug; 31(5):689-694. PubMed ID: 35946080
[TBL] [Abstract] [Full Text] [Related]
9. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract] [Full Text] [Related]
10. A Clinicopathological and Molecular Analysis of Sellar/Suprasellar Neurocytoma Mimicking Pituitary Adenoma.
Zhang L; Fu W; Zheng L; Song F; Chen Y; Jiang C; Xing Z; Hu C; Ye Y; Zhang S; Yan X; Wang X
Front Endocrinol (Lausanne); 2022; 13():861540. PubMed ID: 35663322
[TBL] [Abstract] [Full Text] [Related]
11. SOAT1: A Suitable Target for Therapy in High-Grade Astrocytic Glioma?
Löhr M; Härtig W; Schulze A; Kroiß M; Sbiera S; Lapa C; Mages B; Strobel S; Hundt JE; Bohnert S; Kircher S; Janaki-Raman S; Monoranu CM
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409086
[TBL] [Abstract] [Full Text] [Related]
12. Design of Inhibitors of the Intrinsically Disordered Protein NUPR1: Balance between Drug Affinity and Target Function.
Rizzuti B; Lan W; Santofimia-Castaño P; Zhou Z; Velázquez-Campoy A; Abián O; Peng L; Neira JL; Xia Y; Iovanna JL
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680086
[TBL] [Abstract] [Full Text] [Related]
13. Intrinsic Disorder and Phosphorylation in BRCA2 Facilitate Tight Regulation of Multiple Conserved Binding Events.
Julien M; Ghouil R; Petitalot A; Caputo SM; Carreira A; Zinn-Justin S
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356684
[TBL] [Abstract] [Full Text] [Related]
14. cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance.
Lee M; Shorthouse D; Mahen R; Hall BA; Venkitaraman AR
Nucleic Acids Res; 2021 Jun; 49(10):5588-5604. PubMed ID: 33978741
[TBL] [Abstract] [Full Text] [Related]
15. A pan-cancer perspective analysis reveals the opposite prognostic significance of CD133 in lower grade glioma and papillary renal cell carcinoma.
Wang H; Wang X; Xu L; Zhang J; Cao H
Sci Prog; 2021; 104(2):368504211010938. PubMed ID: 33878963
[TBL] [Abstract] [Full Text] [Related]
16. Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors.
Altan M; Haberal HB; Aşçı A; Güdeloğlu A; Doğrul AB; Yazıcı MS; Akdoğan B; Özen H
Int J Clin Oncol; 2021 Jan; 26(1):186-191. PubMed ID: 32960421
[TBL] [Abstract] [Full Text] [Related]
17. Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma.
Santofimia-Castaño P; Xia Y; Peng L; Velázquez-Campoy A; Abián O; Lan W; Lomberk G; Urrutia R; Rizzuti B; Soubeyran P; Neira JL; Iovanna J
Cells; 2019 Nov; 8(11):. PubMed ID: 31744261
[TBL] [Abstract] [Full Text] [Related]
18. Metabolic profiling reveals distinct metabolic alterations in different subtypes of pituitary adenomas and confers therapeutic targets.
Feng J; Gao H; Zhang Q; Zhou Y; Li C; Zhao S; Hong L; Yang J; Hao S; Hong W; Zhuang Z; Xu G; Zhang Y
J Transl Med; 2019 Aug; 17(1):291. PubMed ID: 31455412
[TBL] [Abstract] [Full Text] [Related]
19. Genetic Causes of Rare Pediatric Ovarian Tumors.
Plevová P; Geržová H
Klin Onkol; 2019; 32(Supplementum2):79-91. PubMed ID: 31409083
[TBL] [Abstract] [Full Text] [Related]
20. Metabolomics in the Diagnosis of Pheochromocytoma and Paraganglioma.
Dwight T; Kim E; Novos T; Clifton-Bligh RJ
Horm Metab Res; 2019 Jul; 51(7):443-450. PubMed ID: 31307108
[TBL] [Abstract] [Full Text] [Related]
[Next]